Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youwen Tan

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Viral Hepatitis|January 26, 2022
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 studyRui Hua, Fei Kong, Xiaofeng Wen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in MASLDFajuan Rui, Jing Zhang, Hongshan Li, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 30, 2020
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeksXiaomei Wang, Zhongfeng Wang, Xiumei Chi, et al.
Eclinicalmedicine|January 31, 2024
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort studyFajuan Rui, Yee Hui Yeo, Liang Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2024
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic SteatosisFajuan Rui, Liang Xu, Yee Hui Yeo, et al.
The Journal of Infection|February 23, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trialMingyuan Zhang, Yanhang Gao, Fei Kong, et al.
Journal of Clinical and Translational Hepatology|October 21, 2020
Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without CirrhosisHuiying Rao, Xingxiang Yang, Youwen Tan, et al.
Infectious Diseases and Therapy|October 19, 2023
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in ChinaRui Hua, Fei Kong, Guangming Li, et al.
Journal of Clinical and Translational Hepatology|October 15, 2019
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in ChinaXiaoyuan Xu, Bo Feng, Yujuan Guan, et al.
Hepatology (Baltimore, Md.)|June 25, 2025
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosisJie Li, Liang Xu, Fajuan Rui, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Viral Hepatitis|January 26, 2022
Efficacy and safety of alfosbuvir plus daclatasvir in Chinese patients with hepatitis C virus genotypes 1, 2, 3, and 6 infection: An open-label, phase 2 studyRui Hua, Fei Kong, Xiaofeng Wen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2026
Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in MASLDFajuan Rui, Jing Zhang, Hongshan Li, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 30, 2020
Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeksXiaomei Wang, Zhongfeng Wang, Xiumei Chi, et al.
Eclinicalmedicine|January 31, 2024
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort studyFajuan Rui, Yee Hui Yeo, Liang Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2024
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic SteatosisFajuan Rui, Liang Xu, Yee Hui Yeo, et al.
The Journal of Infection|February 23, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trialMingyuan Zhang, Yanhang Gao, Fei Kong, et al.
Journal of Clinical and Translational Hepatology|October 21, 2020
Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without CirrhosisHuiying Rao, Xingxiang Yang, Youwen Tan, et al.
Infectious Diseases and Therapy|October 19, 2023
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in ChinaRui Hua, Fei Kong, Guangming Li, et al.
Journal of Clinical and Translational Hepatology|October 15, 2019
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in ChinaXiaoyuan Xu, Bo Feng, Yujuan Guan, et al.
Hepatology (Baltimore, Md.)|June 25, 2025
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosisJie Li, Liang Xu, Fajuan Rui, et al.
Pageof 5